Ferrostatin-1 Blunts Right Ventricular Hypertrophy and Dysfunction in Pulmonary Arterial Hypertension by Suppressing the HMOX1/GSH Signaling
- 21 August 2023
- journal article
- research article
- Published by Springer Nature in Journal of Cardiovascular Translational Research
- Vol. 17 (1) , 183-196
Abstract
Ferroptosis plays a critical role in pulmonary arterial hypertension (PAH)-induced right ventricular (RV) dysfunction, but key genes remain largely unclear. We here identified HMOX1 as an essential ferroptosis-related differentially expressed gene in PAH by bioinformatic analysis using FerrDb, GSE119754, and GSE3675 datasets, respectively. Notably, there were marked increases in HMOX1 and iron levels in RV of monocrotaline-induced PAH rats with reduced TAPSE levels. More importantly, treatment with ferrostatin-1 effectively attenuated RV hypertrophy, remodeling, myocardial fibrosis, and dysfunction in PAH rats. In cultured H9C2 cells and primary neonatal rat cardiomyocytes, pretreatment with ferrostatin-1 and knockdown HMOX1 by siRNA strikingly blunted hypoxia-induced promotion of lipid peroxidation, ferroptosis, and cardiomyocyte injury by potentiating glutathione (GSH) and nitric oxide signaling, respectively. In summary, ferrostatin-1 attenuates RV hypertrophy, fibrosis, and dysfunction in PAH by suppressing the HMOX1/GSH signaling. Targeting HMOX1 ferroptosis signaling functions as a potential therapeutic strategy for patients with PAH. Graphical AbstractKeywords
Funding Information
- National Natural Science Foundation of China (No. 92168117)
- National Science Foundation of Beijing Municipality (NO.7222068)
This publication has 20 references indexed in Scilit:
- Ferroptosis as a target for protection against cardiomyopathyProceedings of the National Academy of Sciences, 2019
- Heme oxygenase-1 protects liver against ischemia/reperfusion injury via phosphoglycerate mutase family member 5-mediated mitochondrial quality controlLife Sciences, 2018
- Apelin Is a Negative Regulator of Angiotensin II–Mediated Adverse Myocardial Remodeling and DysfunctionHypertension, 2017
- Epidemiology and treatment of pulmonary arterial hypertensionNature Reviews Cardiology, 2017
- Pulmonary vascular remodeling in pulmonary hypertensionCell and tissue research, 2016
- Heme oxygenase-1 accelerates erastin-induced ferroptotic cell deathOncotarget, 2015
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- The Right Ventricle Under PressureChest, 2009
- Pathologic assessment of vasculopathies in pulmonary hypertensionJACC, 2004